FDA: Class I recall of Brainlab’s Cranial Image-Guided Surgery System
Editor's Note
The Food and Drug Administration (FDA) on January 15 classified the recall of Brainlab’s Cranial Image-Guided Surgery (IGS) System as Class I, the most serious.
The system is being recalled because of potential inaccuracies in the display by the navigation system compared to the patient’s anatomy. This could lead to inaccurate, ineffective surgical procedures and serious life-threatening injuries, including death.
The recall includes the Cranial IGS and Navigation Systems (all existing versions before Cranial 3.0), distribution dates: May 1996 to May 2015.
Posted 01/15/2016] AUDIENCE: Risk Manager, Surgery ISSUE: Brainlab is recalling the Cranial IGS System due to potential inaccuracies in the display by the navigation system compared to the patient anatomy. This could lead to inaccurate, ineffective medical procedures, and serious life-threatening injuries including death.
Read More >>
Free Daily News
- HCA Healthcare reports solid first-quarter financials
- Per-person healthcare spending grows nearly 19% in 5 years
- OR Manager Conference: Lowest rates expire in one week
- Hospitals boost cybersecurity budgets, staff
- Kentucky passes first-ever state law decriminalizing medical mistakes
- Kaiser Permanente data breach affects 13.4 million
- Study explores link between diverticulitis and colorectal cancer
- State lawmakers target rising healthcare costs via legislation on hospital facility fees
- FDA medical device Class 1 recalls trend upward
- Data cast doubt on recommendation to delay weight-loss meds prior to surgery